We are live on ! Find out more
IART icon

Integra LifeSciences

223 hedge funds and large institutions have $2.96B invested in Integra LifeSciences in 2016 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 95 increasing their positions, 61 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

477% more call options, than puts

Call options by funds: $12M | Put options by funds: $2.08M

185.69% more ownership

Funds ownership: 0%185.69% (+186%)

56% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 61

8% more capital invested

Capital invested by funds: $2.75B → $2.96B (+$211M)

5% less funds holding

Funds holding: 234223 (-11)

22% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 41

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
223
Holders Change
-11
Holders Change %
-4.7%
% of All Funds
5.58%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
32
Increased
95
Reduced
61
Closed
41
Calls
$12M
Puts
$2.08M
Net Calls
+$9.9M
Net Calls Change
+$1.89M
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
26
Millennium Management
New York
$27.7M +$20.5M +505,006 +358%
VNIM
27
Vaughan Nelson Investment Management
Texas
$26.8M +$1.73M +42,650 +7%
O
28
OppenheimerFunds
New York
$25.9M -$9.72M -239,228 -28%
PPA
29
Parametric Portfolio Associates
Washington
$24.5M -$3.4M -83,758 -13%
SGA
30
Sector Gamma AS
Norway
$24.1M -$2.03M -50,000 -8%
Wellington Management Group
31
Wellington Management Group
Massachusetts
$22.6M +$21.4M +526,854 New
Two Sigma Investments
32
Two Sigma Investments
New York
$22.1M +$10.7M +262,682 +104%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$21.4M +$2.24M +55,166 +12%
MFIMFI
34
Mesirow Financial Investment Management - Fixed Income
Illinois
$20.1M -$3.23M -79,490 -14%
Neuberger Berman Group
35
Neuberger Berman Group
New York
$19.6M -$141K -3,460 -0.8%
Principal Financial Group
36
Principal Financial Group
Iowa
$19.4M +$150K +3,698 +0.8%
Ameriprise
37
Ameriprise
Minnesota
$19.2M -$2.71M -66,738 -13%
IAM
38
Impax Asset Management
New Hampshire
$17.5M +$10.1M +248,034 +155%
NFA
39
Nationwide Fund Advisors
Ohio
$17.3M +$1.46M +35,812 +10%
Artisan Partners
40
Artisan Partners
Wisconsin
$16.1M -$1.47M -36,088 -9%
FPC
41
Falcon Point Capital
California
$15.5M +$1.09M +26,868 +8%
CM
42
Castleark Management
Illinois
$15.1M +$1.37M +33,638 +11%
PAM
43
Panagora Asset Management
Massachusetts
$14.6M -$488K -11,996 -3%
Loomis, Sayles & Company
44
Loomis, Sayles & Company
Massachusetts
$14.4M -$11M -269,530 -45%
Bank of America
45
Bank of America
North Carolina
$14.2M +$2.06M +50,700 +18%
TCM
46
Tributary Capital Management
Nebraska
$14.1M +$927K +22,806 +7%
BIM
47
BlackRock Investment Management
Delaware
$13.1M +$2.2M +54,036 +21%
Russell Investments Group
48
Russell Investments Group
United Kingdom
$12.3M +$11.6M +286,360 New
EVM
49
Eaton Vance Management
Massachusetts
$10.4M -$114K -2,802 -1%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$9.9M +$1.58M +38,832 +20%

IART Hedge Fund Activity: Q4 2016 in Review

223 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2016, worth a combined $2.96B — up 7.7% from $2.75B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of IART and 32 opened new positions — a net loss of 9 holders — while 61 trimmed existing stakes and 95 added.

The largest buyer was Invesco, adding an estimated $50.1M. The largest seller was Westwood Holdings Group, cutting an estimated $36.6M.

  • 223 institutional investors held Integra LifeSciences (IART) as of Q4 2016, down from 234 in Q3 2016.
  • Funds reported $2.96B of Integra LifeSciences stock for Q4 2016, up 7.7% quarter-over-quarter.
  • 32 funds opened new Integra LifeSciences positions in Q4 2016 and 41 closed out, a net change of -9 holders.
  • The largest Integra LifeSciences buyer in Q4 2016 was Invesco, an estimated $50.1M added.
  • The largest Integra LifeSciences seller in Q4 2016 was Westwood Holdings Group, an estimated $36.6M sold.

Based on aggregated 13F filings for Q4 2016.